Effects of novel human cathepsin S inhibitors on cell migration in human cancer cells

25Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Elevated cathepsin S (Cat S) level is correlated with higher migration ability in tumor cells. This study investigates the inhibitory effect of novel synthetic α-ketoamide compounds on cathepsin activity and cancer cell migration. The effect of several α-ketoamide compounds on the activity of recombinant cathepsins (Cat S, Cat L and Cat K) was examined. Two highly metastatic cancer cell lines were incubated with three Cat S-specific compounds (6n, 6w and 6r) to analyze their effect on cellular Cat S activity and cell migration. At a 100nM concentration, compounds 6n, 6r and 6w effectively inhibited Cat S activity. Cat S activity and cell migration were significantly reduced in CL1-3 cells after treatment with either 6n or 6w at 5μM. Similar results were also obtained when A2058 cells were treated with 6n. These results highlight the therapeutic potential of α-ketoamide compounds, especially 6n and 6w, to prevent or delay cancer metastasis. © 2014 Informa UK Ltd.

Cite

CITATION STYLE

APA

Tsai, J. Y., Lee, M. J., Chang, M. D. T., Wang, H. C., Lin, C. C., & Huang, H. (2014). Effects of novel human cathepsin S inhibitors on cell migration in human cancer cells. Journal of Enzyme Inhibition and Medicinal Chemistry, 29(4), 538–546. https://doi.org/10.3109/14756366.2013.823957

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free